All data are based on the daily closing price as of October 8, 2025
a
Alfresa Holdings
2784.TSE
13.88 USD
-0.34
-2.39%
Overview
Last close
13.88 usd
Market cap
2.52B usd
52 week high
16.89 usd
52 week low
13.01 usd
Target price
14.58 usd
Valuation
P/E
14.6566
Forward P/E
N/A
Price/Sales
0.1311
Price/Book Value
0.7953
Enterprise Value
1.51B usd
EV/Revenue
0.0778
EV/EBITDA
4.2225
Key financials
Revenue TTM
19.62B usd
Gross Profit TTM
1.41B usd
EBITDA TTM
351.07M usd
Earnings per Share
0.97 usd
Dividend
0.41 usd
Total assets
10.26B usd
Net debt
-1.04B usd
About
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.